A subgroup analysis of small lymphocytic and marginal zone lymphomas in the Eastern Cooperative Oncology Group protocol E4402 (RESORT): A randomized phase III study comparing two different rituximab dosing strategies for low tumor burden indolent non-Hodgkin lymphoma.
Michael E. Williams
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Fangxin Hong
No relevant relationships to disclose
Brad S. Kahl
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Randy D. Gascoyne
Consultant or Advisory Role - Roche/Genentech
Lynne I. Wagner
No relevant relationships to disclose
John C. Krauss
No relevant relationships to disclose
Sandra J. Horning
Employment or Leadership Position - Genentech
Stock Ownership - Genentech